Cargando cotizaciones...
Previsión
| Comprar |
0 |
| Mantener |
0 |
| Vender |
1 |
Debates en la comunidad
Todavía no hay ninguna discusión sobre este activo.
Iniciar debateNoticias Ir al feed de noticias
Corbion cuts adjusted EBITDA margin guidance and shares fall sharply
Corbion lowered its forecast for the adjusted EBITDA margin for 2026 to above 16% (previously around 17%), sending the share price down about 3.8%. Management cited macroeconomic uncertainty and unexpected cost inflation from the Middle East conflict (commodity prices, freight rates, energy costs) as reasons. The revenue growth target (organic 3–6%) and free cash flow (€85–90m) remained unchanged, but weak cash generation in Q2 and a working-capital outflow amplified the market reaction. Analysts viewed the margin revision as negative and the share move as company-specific rather than market-wide. » Más en de.investing.com
Corbion Q1 2026: revenue stable, margins under pressure and stock falls
Corbion reported Q1 2026 revenue of €294 million and adjusted EBITDA of €37.8 million (margin 12.9%). The stock fell 6.08% to €19.24 after the figures. The Functional Ingredients & Solutions segment is under margin pressure, while Health & Nutrition benefits from robust demand. Free cash flow was seasonally at -€15.7 million; management confirms full-year FCF of €85–90 million and expects near-term improvements from cost reductions. » Más en de.investing.com
Corbion: undiluted earnings per share in 2025 rise 63% to €1.29 thanks to margin expansion
Corbion reports undiluted earnings per share of €1.29 for 2025 (+63.3%), driven by a significant expansion in margins; net revenue was €1,267.4m, adjusted EBITDA €204.3m (margin 16.1%, +250 basis points). In Q4, volume and mix growth and organic adjusted EBITDA accelerated, and free cash flow for the year amounted to €90.8m. The board proposes a total distribution of €1.00 per share (€0.64 regular, €0.36 special dividend); net debt fell to 1.5x EBITDA. For 2026 Corbion expects organic revenue growth of 3–6%, an adjusted EBITDA margin of around 17% and free cash flow of €85–90m; in the short term Q1 2026 is likely to be below the strong prior year, and negative currency effects weighed on the market reaction. » Más en de.investing.com
Corbion presents "BRIGHT 2030" strategy and drags down stock
Corbion presented the "BRIGHT 2030" strategy with financial targets for 2026–2028: organic revenue growth of 3–6% per year, an EBITDA margin of about 18% by 2028, cumulative free cash flow of €270 million, and a rise in ROCE to around 13%. Management also aims for double‑digit annual earnings‑per‑share growth. Investors reacted negatively; the stock posted continuous losses after the announcement. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | junio de 2026 | YoY |
|---|---|---|
| Ingresos | 631,1 M | - |
| Beneficio bruto | 154,4 M | - |
| Beneficio neto | 29,8 M | - |
| EBITDA | 88,8 M | - |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 1530,57 M € |
Número de acciones | 57,63 M |
Máximo/mínimo de 52 semanas | 27,76 € - 17,26 € |
Rentabilidad por dividendo | 3,77 % |
Dividendos TTM | 1,00 € |
Beta | 0,87 |
Ratio P/E | 24,59 |
Ratio PEG | -2,90 |
Ratio P/B | 2,03 |
Ratio P/S | 1,22 |
Perfil de la empresa
Corbion N.V. produce ácido láctico y derivados del ácido láctico, emulsionantes, mezclas de enzimas funcionales, minerales, vitaminas e ingredientes a base de algas en todo el mundo. La empresa ofrece soluciones de ingredientes elaboradas a partir de recursos renovables para los mercados de alimentación, cuidado del hogar y personal, farmacéutico, nutrición animal, productos sanitarios y bioplásticos. Comercializa sus productos a través de una red de oficinas de ventas y distribuidores. La compañía era conocida anteriormente como CSM N.V. y cambió su nombre a Corbion N.V. en octubre de 2013. Corbion N.V. fue fundada en 1919 y tiene su sede en Ámsterdam, Países Bajos.
| Nombre | Corbion |
| CEO | Olivier Rigaud |
| Sede | Amsterdam,
nh Países Bajos |
| Sitio web | |
| Salida a bolsa | 29/03/1995 |
| Empleados | 2363 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
Euronext | CRBN.AS |
Pnk | CSNVF |
Amsterdam | CRBN.AS |
Frankfurt | CSUA.F |
Düsseldorf | CSUA.DU |
London | 0QHL.L |
SIX | CSUA.SW |
München | CSUA.MU |